Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Glympse Bio Inc.
Headquarters: Cambridge, MA, United States of America
Website: N/A
Year Founded: 2015
Status: Merged
BioCentury | Nov 22, 2023
Emerging Company Profile
Sunbird: blood-based diagnostics via exosomes and proteases
Singapore-based Sunbird hopes to roll out its exosome-based Alzheimer’s test in 2025
BioCentury | Nov 15, 2023
Deals
Alkermes oncology spinout Mural charts its future
Newly independent cancer biotech looks to twin 2025 readouts of IL-2 program that leads pipeline of engineered cytokine therapeutics
BioCentury | Aug 10, 2023
Finance
Aug. 9 Quick Takes: Alltrna raises $109M for unified approach to stop codon diseases
Plus: Venture cash for ADARx, Georgiamune, Neurophth and updates from Regeneron-Decibel, Novartis, Sunbird-Glympse, Denali-Takeda and more
BioCentury | Jun 1, 2023
Management Tracks
Alkermes picks Loew to lead oncology spinout
Plus: Two new SVPs at Dragonfly, and updates from Abilita, OcuTerra and PineTree
BioCentury | Oct 17, 2022
Management Tracks
Baranowski becomes CEO at Avalyn
Plus new CMO at Ankyra as Kaufman becomes CEO, and updates from Verge, Zentalis, Aviceda and more
BioCentury | May 18, 2022
Management Tracks
Fromen to leave PacBio as CCO
Plus Vraniak joins Inversago as CFO and updates from Thabor, Glympse, Civetta and more
BioCentury | Oct 23, 2021
Discovery & Translation
ESGCT preclinical roundup; plus Generation, Pionyr and more
BioCentury’s roundup of translational news
BioCentury | Sep 11, 2021
Management Tracks
New CEO for Eden following conviction of JHL execs
Plus: Mavilio, Loggia join Orchard and updates from PMV, Verseau, Apexigen, VectivBio, Protagonist and more
BioCentury | Jul 21, 2021
Management Tracks
Passage Bio builds out C-suite
Plus: Rome, Adagio, Iveric, Renovacor and more
BioCentury | Jul 15, 2020
Emerging Company Profile
Glympse raises $47.6M to test biosensors that could improve on liver biopsies in NASH
Section 32 led Glympse's series B round, which will also fund clinical testing of an oncology program
Items per page:
1 - 10 of 19